Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

Spremljeno u:
Bibliografski detalji
Izdano u:Haematologica
Glavni autori: Breccia, Massimo, Abruzzese, Elisabetta, Iurlo, Alessandra, Gozzini, Antonella, Isidori, Alessandro, Gangemi, Domenica, Pregno, Patrizia, Alimena, Giuliana
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2016
Teme:
Online Only Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013958/
https://ncbi.nlm.nih.gov/pubmed/27252515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.145623
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items